Cormorant Asset Management’s ADARx Pharmaceuticals ADRX Stock Holding History
Bought
Maintained
Sold
Other funds holding ADRX
SL
Cormorant Asset Management's ADRX Position: Q3 2026 in Review
Cormorant Asset Management opened a new position in ADARx Pharmaceuticals (ADRX) in Q3 2026: 962,898 shares worth $19.2M. The stake represents 1.29% of the portfolio and ranks #24 among its holdings.
62 funds tracked by Wall St. Rank hold ADRX as of Q3 2026.
- Cormorant Asset Management held 962,898 shares of ADARx Pharmaceuticals worth $19.2M as of Q3 2026.
- ADARx Pharmaceuticals was a new Cormorant Asset Management position in Q3 2026.
- ADARx Pharmaceuticals made up 1.29% of Cormorant Asset Management's portfolio in Q3 2026, its #24 holding.
- 62 funds tracked by Wall St. Rank held ADARx Pharmaceuticals as of Q3 2026.
Based on Cormorant Asset Management's 13F filing for Q3 2026, filed 16 Nov 2026.